Mm-hmm, right.

And by lowering the amount of amyloid plaques and clearing the brain of this process, the functional decline, the memory loss, the thinking difficulties, the progression of the disease slows down.

It's very important to understand this is not a cure, but this does slow down the progression, which is very important because like for Scott, he's able to interact with his family, participate in the community, and be independent with his activities much longer because now he has this treatment that's going to slow down progression.

Why was Broward Health North and your center chosen to conduct the Kusunla trial here in South Florida?

So this is an FDA-approved medication.

It became FDA-approved in July of 2024.

Scott is one of the first patients to start the medication once it became FDA-approved.

and he completed the 18 months of treatment.